Thinking Beyond Science

Imagine testing 100 cancer samples and finding genetic mutations in every single one. Easy conclusion: mutations cause cancer. But hold on—that logic crumbles without the denominator. What if 100 non-cancerous tissue samples also have mutations? Suddenly, those changes look far less suspicious. They’re common, not causative. This simple oversight shows how we often chase shiny distractions instead of true root causes in disease.

For any illness, grasping the etiology—the root cause—fuels real treatment. Proximate causes, those obvious intermediate steps, grab headlines but miss the mark. Take liver failure: it’s triggered by cirrhosis, fibrotic scarring. True, but useless without digging deeper. Is it hepatitis C virus? Prescribe antivirals. Chronic alcohol? Counsel abstinence. Cirrhosis is just proximate; success demands the ultimate why.

Cells operate like finely tuned watches—every part purposeful, no room for chaos. Randomly yanking a screw rarely improves a watch; it malfunctions. Same in cells: a random mutation is more likely harmful or lethal than a superpower. Assembling 50-200 mutations by chance without killing the cell? Odds slimmer than winning Powerball. Mutation rates in populations are tiny, far too low to spark rampant cancer. Random assembly into coherent, cancer-driving changes should make cancer vanishingly rare. Yet it’s everywhere.

Precision medicine promised salvation: spot patient-specific mutations, deliver targeted drugs. We’ve nailed detection—thousands of variants identified. But delivery? Drug development is a risky grind; even winners flop on side effects. Smarter play: copy successes. If Company A blocks gene target A, five rivals tweak a side-chain molecule, dodge patents, and flood the market with near-identical me-toos. Low risk, high profit. Innovation starves.

Enter epigenetics, from Greek “epi-” meaning “over” or “above.” It studies gene regulation beyond DNA mutations—how genes turn on or off. Diet, exercise, environment: these tweak expression. Epigenetics flips the script on DNA supremacy. Packaging matters as much as—or more than—the genetic code itself, and environment calls the shots.

To understand this, rewind to life’s origins. Earliest cells formed when self-replicating RNA huddled inside protective phospholipid bilayers, our cells’ enduring membrane tech. They floated in nutrient seas, surviving precariously. Life’s prime directive? Replicate. That drove growth, energy production, mobility—imperatives even viruses chase, hijacking hosts to copy themselves.

Prokaryotes emerged first from the primordial soup—simple, hardy. Billions of years later, eukaryotes added complexity: nuclei housing reproduction genes, organelles for specialized tasks like protein-making and energy. Mitochondria stand out, energy powerhouses via ATP from oxidative phosphorylation (OxPhos). They started as independent prokaryotes, partnering with early eukaryotes in symbiosis. Today, they’re inseparable—mitochondria in every mammalian cell except red blood cells (which ditch them for oxygen transport). With their own DNA echoing ancient roots, mitochondria also orchestrate apoptosis, controlled cell suicide.

Cancer thrives not from mutation lotteries, but ignored root causes, epigenetic levers, and life’s relentless replication drive. Chasing genes alone misses the forest for the trees. True breakthroughs demand holistic views—etiology over symptoms, environment over inevitability.

Source : The Cancer Code: A Revolutionary New Understanding of a Medical Mystery by Jason Fung

Goodreads : https://www.goodreads.com/book/show/52163526-the-cancer-code

Read the Previous Article in the Series :